BioSig Technologies, Inc. – NASDAQ:BSGM
Founder-led company
BioSig Technologies stock price today
$4.875
+3.39
+229.39%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 3 days
BioSig Technologies stock price monthly change
+252.38%
month
BioSig Technologies stock price quarterly change
+252.38%
quarter
BioSig Technologies stock price yearly change
+203.09%
year
BioSig Technologies key metrics
Market Cap | 22.66M |
Enterprise value | 47.74M |
P/E | -1.78 |
EV/Sales | 158.10 |
EV/EBITDA | -1.16 |
Price/Sales | 158.10 |
Price/Book | 152551.13 |
PEG ratio | -0.05 |
EPS | -3.23 |
Revenue | N/A |
EBITDA | -23.95M |
Income | -25.11M |
Revenue Q/Q | 180% |
Revenue Y/Y | -90.45% |
Profit margin | -13573.84% |
Oper. margin | -13591.39% |
Gross margin | 81.13% |
EBIT margin | -13591.39% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeBioSig Technologies stock price history
BioSig Technologies stock forecast
BioSig Technologies financial statements
| Jun 2023 | 0 | -11.09M | |
|---|---|---|---|
| Sep 2023 | 1K | -4.56M | -456900% |
| Dec 2023 | 12K | -6.04M | -50408.33% |
| Mar 2024 | 14K | -3.40M | -24300% |
| Mar 2024 | 14K | -3.40M | -24300% |
|---|---|---|---|
| Sep 2025 | 300K | -3.25M | -1084.8% |
| Oct 2025 | 100K | -2.56M | -2562.63% |
| Dec 2025 | 200K | -985.62K | -492.81% |
Analysts Price target
Financials & Ratios estimates
| 2022-08-15 | -0.19 | -0.15 |
|---|---|---|
| 2022-11-14 | -0.14 | -0.14 |
| 2023-03-13 | -0.11 | -0.16431 |
| 2023-05-15 | -0.1 | -0.12 |
0%
Yield TTM
| Payout ratio | 0% |
|---|
| 2019 | 0.33% |
|---|---|
| 2020 | 0.17% |
| 2021 | 0.01% |
| 2022 | 0.05% |
| 2023 | 0.03% |
| Jun 2023 | 4050000 | 3.61M | 89.23% |
|---|---|---|---|
| Sep 2023 | 3154000 | 4.10M | 130.12% |
| Dec 2023 | 1798000 | 4.68M | 260.57% |
| Mar 2024 | 1589000 | 5.79M | 364.51% |
| Jun 2023 | -4.89M | -77K | 4.81M |
|---|---|---|---|
| Sep 2023 | -3.82M | -60K | 3.02M |
| Dec 2023 | -2.94M | -4K | 2.74M |
| Mar 2024 | -1.31M | 0 | 1.54M |
BioSig Technologies alternative data
| Aug 2023 | 47 |
|---|---|
| Sep 2023 | 47 |
| Oct 2023 | 47 |
| Nov 2023 | 47 |
| Dec 2023 | 47 |
| Jan 2024 | 47 |
| Feb 2024 | 47 |
| Mar 2024 | 47 |
| Apr 2024 | 47 |
| May 2024 | 4 |
| Jun 2024 | 4 |
| Jul 2024 | 4 |
BioSig Technologies other data
6.59%
-5.71%
of BSGM is owned by hedge funds
34
-11
2.29M
-1.99M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Aug 2022 | 134776 | 0 |
| Sep 2022 | 105681 | 0 |
| Feb 2023 | 349323 | 0 |
| May 2023 | 8000 | 0 |
| Jun 2023 | 26200 | 0 |
| Patent |
|---|
Application Filling date: 2 Feb 2022 Issue date: 18 Aug 2022 |
Application Filling date: 13 Apr 2022 Issue date: 11 Aug 2022 |
Grant Filling date: 25 Sep 2019 Issue date: 10 May 2022 |
Application Filling date: 16 Sep 2021 Issue date: 14 Apr 2022 |
Application Filling date: 25 Aug 2021 Issue date: 3 Mar 2022 |
Grant Utility: Universal notch filter Filling date: 6 Nov 2020 Issue date: 1 Mar 2022 |
Application Filling date: 7 Aug 2020 Issue date: 10 Feb 2022 |
Grant Filling date: 22 Dec 2020 Issue date: 25 Jan 2022 |
Application Filling date: 26 Apr 2021 Issue date: 11 Nov 2021 |
Grant Filling date: 8 Oct 2020 Issue date: 21 Sep 2021 |
| Insider | Compensation |
|---|---|
Mr. Kenneth L. Londoner M.B.A., MBA (1968) Founder, Chief Executive Officer & Executive Chairman | $1,200,000 |
-
What's the price of BioSig Technologies stock today?
One share of BioSig Technologies stock can currently be purchased for approximately $4.88.
-
When is BioSig Technologies's next earnings date?
Unfortunately, BioSig Technologies's (BSGM) next earnings date is currently unknown.
-
Does BioSig Technologies pay dividends?
No, BioSig Technologies does not pay dividends.
-
How much money does BioSig Technologies make?
BioSig Technologies has a market capitalization of 22.66M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 93.71% to 18K US dollars. BioSig Technologies made a loss 29.04M US dollars in net income (profit) last year or -$0.12 on an earnings per share basis.
-
What is BioSig Technologies's stock symbol?
BioSig Technologies, Inc. is traded on the NASDAQ under the ticker symbol "BSGM".
-
What is BioSig Technologies's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of BioSig Technologies?
Shares of BioSig Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are BioSig Technologies's key executives?
BioSig Technologies's management team includes the following people:
- Mr. Kenneth L. Londoner M.B.A., MBA Founder, Chief Executive Officer & Executive Chairman(age: 57, pay: $1,200,000)
-
Is BioSig Technologies founder-led company?
Yes, BioSig Technologies is a company led by its founder Mr. Kenneth L. Londoner M.B.A., MBA.
-
How many employees does BioSig Technologies have?
As Jul 2024, BioSig Technologies employs 4 workers, which is 91% less then previous quarter.
-
When BioSig Technologies went public?
BioSig Technologies, Inc. is publicly traded company for more then 10 years since IPO on 31 Oct 2014.
-
What is BioSig Technologies's official website?
The official website for BioSig Technologies is biosig.com.
-
Where are BioSig Technologies's headquarters?
BioSig Technologies is headquartered at 55 Greens Farms Road, Westport, CT.
-
How can i contact BioSig Technologies?
BioSig Technologies's mailing address is 55 Greens Farms Road, Westport, CT and company can be reached via phone at +20 3 4095444.
BioSig Technologies company profile:
BioSig Technologies, Inc.
biosig.comExchange:
NASDAQ
Full time employees:
4
Industry:
Medical - Devices
Sector:
Healthcare
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
55 Greens Farms Road
Westport, CT 06880
Westport, CT 06880
CIK: 0001530766
ISIN: US09073N3008
CUSIP: 09073N201
